Most decaf brands still can have some caffeine
Konig SA, Siemes H, Blaker F, Boenigk E, Gross-Selbeck G, Hanefeld F, Haas N, Kohler B, Koelfen W, Korinthenberg R, et al .: Severe hepatotoxicity during valproate therapy: an update and report of eight new fatalities
Further population-based studies may quantify incidence rates, characterize dose-dependent relationships, and investigate mechanistic pathways to optimize risk stratification and therapeutic decision-making
You might be administering 250mcg when you think you're administering 500mcg, or vice-versa
Disclaimer This article is for educational purposes only and is not medical advice
File a complaint or consult a lawyer if your plan was misleading during enrollment